Clinical trial
Combination Chemotherapy in Treating Patients With Advanced Stomach Cancer
NCT00004873 · Swiss Cancer Institute, Other · Completed
Key facts
| NCT number | NCT00004873 |
|---|---|
| Title | Combination Chemotherapy in Treating Patients With Advanced Stomach Cancer |
| Official title | Taxotere-Cisplatin-5FU (TCF) Versus Taxotere-Cisplatin (TC) Versus Epirubicin-Cisplatin-5FU (ECF) as Systemic Treatment for Advanced Gastric Carcinoma: A Randomized Phase II Trial |
| Lead sponsor | Swiss Cancer Institute, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Gastric Cancer |
| Intervention type | Drug |
| Interventions | cisplatin, docetaxel, epirubicin hydrochloride, fluorouracil |
| Start date | Aug 1, 1999 |
| Primary completion | Jul 1, 2003 |
| Completion | Jul 1, 2003 |
| First posted | Jan 27, 2003 |
| Last update posted | May 15, 2012 |
| Countries | Switzerland |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: